{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,30]],"date-time":"2026-03-30T10:14:59Z","timestamp":1774865699395,"version":"3.50.1"},"reference-count":38,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,12,10]],"date-time":"2019-12-10T00:00:00Z","timestamp":1575936000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2019,12,10]],"date-time":"2019-12-10T00:00:00Z","timestamp":1575936000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Several recent publications demonstrated that DRD2-targeting antipsychotics such as thioridazine induce proliferation arrest and apoptosis in diverse cancer cell types including those derived from brain, lung, colon, and breast. While most studies show that 10\u201320\u2009\u00b5M thioridazine leads to reduced proliferation or increased apoptosis, here we show that lower doses of thioridazine (1\u20132\u2009\u00b5M) target the self-renewal of basal-like breast cancer cells, but not breast cancer cells of other subtypes. We also show that all breast cancer cell lines tested express DRD2 mRNA and protein, regardless of thioridazine sensitivity. Further, DRD2 stimulation with quinpirole, a DRD2 agonist, promotes self-renewal, even in cell lines in which thioridazine does not inhibit self-renewal. This suggests that DRD2 is capable of promoting self-renewal in these cell lines, but that it is not active. Further, we show that dopamine can be detected in human and mouse breast tumor samples. This observation suggests that dopamine receptors may be activated in breast cancers, and is the first time to our knowledge that dopamine has been directly detected in human breast tumors, which could inform future investigation into DRD2 as a therapeutic target for breast cancer.<\/jats:p>","DOI":"10.1038\/s41598-019-55145-3","type":"journal-article","created":{"date-parts":[[2019,12,10]],"date-time":"2019-12-10T11:03:32Z","timestamp":1575975812000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["Selective Effects of Thioridazine on Self-Renewal of Basal-Like Breast Cancer Cells"],"prefix":"10.1038","volume":"9","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1340-9254","authenticated-orcid":false,"given":"Matthew","family":"Tegowski","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cheng","family":"Fan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Albert S.","family":"Baldwin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2019,12,10]]},"reference":[{"key":"55145_CR1","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1152\/physrev.1998.78.1.189","volume":"78","author":"C Missale","year":"1998","unstructured":"Missale, C., Nash, S. R., Robinson, S. W., Jaber, M. & Caron, M. G. Dopamine Receptors: From Structure to Function. Physiol. Rev. 78, 189\u2013225 (1998).","journal-title":"Physiol. Rev."},{"key":"55145_CR2","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1124\/pr.110.002642","volume":"63","author":"J-M Beaulieu","year":"2011","unstructured":"Beaulieu, J.-M. & Gainetdinov, R. R. The Physiology, Signaling, and Pharmacology of Dopamine Receptors. Pharmacol. Rev. 63, 182\u2013217 (2011).","journal-title":"Pharmacol. Rev."},{"key":"55145_CR3","doi-asserted-by":"publisher","first-page":"1523","DOI":"10.1152\/physrev.2000.80.4.1523","volume":"80","author":"ME Freeman","year":"2000","unstructured":"Freeman, M. E., Kanyicska, B., Lerant, A. & Nagy, G. Prolactin: Structure, Function, and Regulation of Secretion. Physiol. Rev. 80, 1523\u20131631 (2000).","journal-title":"Physiol. Rev."},{"key":"55145_CR4","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1161\/hy0901.096422","volume":"38","author":"RM Carey","year":"2001","unstructured":"Carey, R. M. Renal Dopamine System. Hypertension 38, 297\u2013302 (2001).","journal-title":"Hypertension"},{"key":"55145_CR5","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1016\/j.bbi.2009.10.015","volume":"24","author":"C Sarkar","year":"2010","unstructured":"Sarkar, C., Basu, B., Chakroborty, D., Dasgupta, P. S. & Basu, S. The immunoregulatory role of dopamine: an update. Brain. Behav. Immun. 24, 525\u20138 (2010).","journal-title":"Brain. Behav. Immun."},{"key":"55145_CR6","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1111\/apha.12476","volume":"216","author":"M Levite","year":"2016","unstructured":"Levite, M. Dopamine and T cells: dopamine receptors and potent effects on T cells, dopamine production in T cells, and abnormalities in the dopaminergic system in T cells in autoimmune, neurological and psychiatric diseases. Acta Physiol. (Oxf). 216, 42\u201389 (2016).","journal-title":"Acta Physiol. (Oxf)."},{"key":"55145_CR7","first-page":"5399","volume":"50","author":"JS Strobl","year":"1990","unstructured":"Strobl, J. S. et al. Inhibition of human breast cancer cell proliferation in tissue culture by the neuroleptic agents pimozide and thioridazine. Cancer Res. 50, 5399\u2013405 (1990).","journal-title":"Cancer Res."},{"key":"55145_CR8","first-page":"186","volume":"263","author":"JS Strobl","year":"1992","unstructured":"Strobl, J. S. & Peterson, V. A. Tamoxifen-resistant human breast cancer cell growth: inhibition by thioridazine, pimozide and the calmodulin antagonist, W-13. J. Pharmacol. Exp. Ther. 263, 186\u201393 (1992).","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"55145_CR9","doi-asserted-by":"publisher","first-page":"1284","DOI":"10.1016\/j.cell.2012.03.049","volume":"149","author":"E Sachlos","year":"2012","unstructured":"Sachlos, E. et al. Identification of Drugs Including a Dopamine Receptor Antagonist that Selectively Target Cancer Stem Cells. Cell 149, 1284\u20131297 (2012).","journal-title":"Cell"},{"key":"55145_CR10","doi-asserted-by":"crossref","first-page":"882","DOI":"10.18632\/oncotarget.1801","volume":"5","author":"J Li","year":"2014","unstructured":"Li, J. et al. Genome-wide shRNA screen revealed integrated mitogenic signaling between dopamine receptor D2 (DRD2) and epidermal growth factor receptor (EGFR) in glioblastoma. Oncotarget 5, 882\u2013893 (2014).","journal-title":"Oncotarget"},{"issue":"7","key":"55145_CR11","doi-asserted-by":"publisher","first-page":"1735","DOI":"10.1002\/ijc.31912","volume":"144","author":"Tor\u2010Christian Johannessen","year":"2018","unstructured":"Johannessen, T.-C. A. et al. Thioridazine inhibits autophagy and sensitizes glioblastoma cells to temozolomide. Int. J. Cancer, https:\/\/doi.org\/10.1002\/ijc.31912 (2018).","journal-title":"International Journal of Cancer"},{"key":"55145_CR12","doi-asserted-by":"publisher","first-page":"6709828","DOI":"10.1155\/2016\/6709828","volume":"2016","author":"H Yue","year":"2016","unstructured":"Yue, H. et al. Targeting Lung Cancer Stem Cells with Antipsychological Drug Thioridazine. Biomed Res. Int. 2016, 6709828 (2016).","journal-title":"Biomed Res. Int."},{"key":"55145_CR13","doi-asserted-by":"publisher","first-page":"1168","DOI":"10.3892\/or.2016.5313","volume":"37","author":"C Zhang","year":"2016","unstructured":"Zhang, C. et al. Thioridazine elicits potent antitumor effects in colorectal cancer stem cells. Oncol. Rep. 37, 1168\u20131174 (2016).","journal-title":"Oncol. Rep."},{"key":"55145_CR14","first-page":"8171","volume":"14","author":"M Yong","year":"2017","unstructured":"Yong, M. et al. DR2 blocker thioridazine: A promising drug for ovarian cancer therapy. Oncol. Lett. 14, 8171\u20138177 (2017).","journal-title":"Oncol. Lett."},{"key":"55145_CR15","doi-asserted-by":"publisher","first-page":"4103","DOI":"10.3892\/mmr.2015.3967","volume":"12","author":"T Yin","year":"2015","unstructured":"Yin, T. et al. Dopamine receptor antagonist thioridazine inhibits tumor growth in a murine breast cancer model. Mol. Med. Rep. 12, 4103\u20138 (2015).","journal-title":"Mol. Med. Rep."},{"key":"55145_CR16","doi-asserted-by":"publisher","first-page":"15977","DOI":"10.1074\/jbc.RA118.003719","volume":"293","author":"M Tegowski","year":"2018","unstructured":"Tegowski, M., Fan, C. & Baldwin, A. S. Thioridazine inhibits self-renewal in breast cancer cells via DRD2-dependent STAT3 inhibition, but induces a G1 arrest independent of DRD2. J. Biol. Chem. 293, 15977\u201315990 (2018).","journal-title":"J. Biol. Chem."},{"key":"55145_CR17","doi-asserted-by":"publisher","first-page":"7","DOI":"10.3322\/caac.21442","volume":"68","author":"RL Siegel","year":"2018","unstructured":"Siegel, R. L., Miller, K. D. & Jemal, A. Cancer statistics, 2018. CA. Cancer J. Clin. 68, 7\u201330 (2018).","journal-title":"CA. Cancer J. Clin."},{"key":"55145_CR18","doi-asserted-by":"publisher","first-page":"747","DOI":"10.1038\/35021093","volume":"406","author":"CM Perou","year":"2000","unstructured":"Perou, C. M. et al. Molecular portraits of human breast tumours. Nature 406, 747\u2013752 (2000).","journal-title":"Nature"},{"key":"55145_CR19","doi-asserted-by":"publisher","DOI":"10.1186\/bcr2635","volume":"12","author":"A Prat","year":"2010","unstructured":"Prat, A. et al. Phenotypic and molecular characterization of the claudin-low intrinsic subtype of breast cancer. Breast Cancer Res. 12, R68 (2010).","journal-title":"Breast Cancer Res."},{"key":"55145_CR20","doi-asserted-by":"publisher","first-page":"7350","DOI":"10.1200\/JCO.2005.03.3845","volume":"23","author":"JD Brenton","year":"2005","unstructured":"Brenton, J. D., Carey, L. A., Ahmed, A. A. & Caldas, C. Molecular classification and molecular forecasting of breast cancer: ready for clinical application? J. Clin. Oncol. 23, 7350\u201360 (2005).","journal-title":"J. Clin. Oncol."},{"key":"55145_CR21","doi-asserted-by":"publisher","first-page":"1938","DOI":"10.1056\/NEJMra1001389","volume":"363","author":"WD Foulkes","year":"2010","unstructured":"Foulkes, W. D., Smith, I. E. & Reis-Filho, J. S. Triple-Negative Breast Cancer. N. Engl. J. Med. 363, 1938\u20131948 (2010).","journal-title":"N. Engl. J. Med."},{"key":"55145_CR22","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1016\/j.molonc.2010.11.003","volume":"5","author":"A Prat","year":"2011","unstructured":"Prat, A. & Perou, C. M. Deconstructing the molecular portraits of breast cancer. Mol. Oncol. 5, 5\u201323 (2011).","journal-title":"Mol. Oncol."},{"key":"55145_CR23","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1038\/nature11691","volume":"492","author":"J Besnard","year":"2012","unstructured":"Besnard, J. et al. Automated design of ligands to polypharmacological profiles. Nature 492, 215\u2013220 (2012).","journal-title":"Nature"},{"key":"55145_CR24","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1007\/s10549-013-2743-3","volume":"142","author":"A Prat","year":"2013","unstructured":"Prat, A. et al. Characterization of cell lines derived from breast cancers and normal mammary tissues for the study of the intrinsic molecular subtypes. Breast Cancer Res. Treat. 142, 237\u2013255 (2013).","journal-title":"Breast Cancer Res. Treat."},{"key":"55145_CR25","doi-asserted-by":"publisher","first-page":"1101","DOI":"10.1007\/s00726-017-2408-3","volume":"49","author":"T Stojanovic","year":"2017","unstructured":"Stojanovic, T. et al. Validation of dopamine receptor DRD1 and DRD2 antibodies using receptor deficient mice. Amino Acids 49, 1101\u20131109 (2017).","journal-title":"Amino Acids"},{"key":"55145_CR26","unstructured":"Jarvie, K. R., Niznik, H. B. & Seeman, P. Dopamine D2 receptor binding subunits of Mr congruent to 140,000 and 94,000 in brain: deglycosylation yields a common unit of Mr congruent to 44,000. Mol. Pharmacol. 34 (1988)."},{"key":"55145_CR27","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1093\/oxfordjournals.jbchem.a122809","volume":"106","author":"KR Jarvie","year":"1989","unstructured":"Jarvie, K. R. & Niznik, H. B. Deglycosylation and proteolysis of photolabeled D2 dopamine receptors of the porcine anterior pituitary. J. Biochem. 106, 17\u201322 (1989).","journal-title":"J. Biochem."},{"key":"55145_CR28","doi-asserted-by":"publisher","first-page":"4129","DOI":"10.1002\/j.1460-2075.1988.tb03307.x","volume":"7","author":"RA Williamson","year":"1988","unstructured":"Williamson, R. A., Worrall, S., Chazot, P. L. & Strange, P. G. Purification of brain D2 dopamine receptor. EMBO J. 7, 4129\u201333 (1988).","journal-title":"EMBO J."},{"key":"55145_CR29","doi-asserted-by":"publisher","first-page":"15641","DOI":"10.1074\/jbc.M110.188078","volume":"286","author":"S Yoon","year":"2011","unstructured":"Yoon, S., Choi, M., Chang, M. S. & Baik, J.-H. Wnt5a-dopamine D2 receptor interactions regulate dopamine neuron development via extracellular signal-regulated kinase (ERK) activation. J. Biol. Chem. 286, 15641\u201351 (2011).","journal-title":"J. Biol. Chem."},{"key":"55145_CR30","doi-asserted-by":"publisher","first-page":"7016","DOI":"10.1073\/pnas.1018280108","volume":"108","author":"JL Swift","year":"2011","unstructured":"Swift, J. L. et al. Quantification of receptor tyrosine kinase transactivation through direct dimerization and surface density measurements in single cells. Proc. Natl. Acad. Sci. USA 108, 7016\u201321 (2011).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"5","key":"55145_CR31","doi-asserted-by":"publisher","first-page":"1123","DOI":"10.1002\/stem.2596","volume":"35","author":"Theresa Relation","year":"2017","unstructured":"Relation, T., Dominici, M. & Horwitz, E. M. Concise Review: An (Im)Penetrable Shield: How the Tumor Microenvironment Protects Cancer Stem Cells. Stem Cells, https:\/\/doi.org\/10.1002\/stem.2596 (2017).","journal-title":"STEM CELLS"},{"key":"55145_CR32","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/j.stem.2018.12.009","volume":"24","author":"BC Prager","year":"2019","unstructured":"Prager, B. C., Xie, Q., Bao, S. & Rich, J. N. Cancer Stem Cells: The Architects of the Tumor Ecosystem. Cell Stem Cell 24, 41\u201353 (2019).","journal-title":"Cell Stem Cell"},{"key":"55145_CR33","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1046\/j.1365-2567.1996.d01-653.x","volume":"88","author":"E Josefsson","year":"1996","unstructured":"Josefsson, E., Bergquist, J., Ekman, R. & Tarkowski, A. Catecholamines are synthesized by mouse lymphocytes and regulate function of these cells by induction of apoptosis. Immunology 88, 140\u20136 (1996).","journal-title":"Immunology"},{"key":"55145_CR34","doi-asserted-by":"publisher","first-page":"3160486","DOI":"10.1155\/2016\/3160486","volume":"2016","author":"R Arreola","year":"2016","unstructured":"Arreola, R. et al. Immunomodulatory Effects Mediated by Dopamine. J. Immunol. Res. 2016, 3160486 (2016).","journal-title":"J. Immunol. Res."},{"key":"55145_CR35","doi-asserted-by":"publisher","first-page":"1236361","DOI":"10.1126\/science.1236361","volume":"341","author":"C Magnon","year":"2013","unstructured":"Magnon, C. et al. Autonomic Nerve Development Contributes to Prostate Cancer Progression. Science (80-.). 341, 1236361\u20131236361 (2013).","journal-title":"Science (80-.)."},{"key":"55145_CR36","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1126\/science.aah5072","volume":"358","author":"AH Zahalka","year":"2017","unstructured":"Zahalka, A. H. et al. Adrenergic nerves activate an angio-metabolic switch in prostate cancer. Science (80-.). 358, 321\u2013326 (2017).","journal-title":"Science (80-.)."},{"key":"55145_CR37","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1016\/j.bbi.2015.12.014","volume":"53","author":"MJ Szpunar","year":"2016","unstructured":"Szpunar, M. J., Belcher, E. K., Dawes, R. P. & Madden, K. S. Sympathetic innervation, norepinephrine content, and norepinephrine turnover in orthotopic and spontaneous models of breast cancer. Brain. Behav. Immun. 53, 223\u2013233 (2016).","journal-title":"Brain. Behav. Immun."},{"key":"55145_CR38","first-page":"506","volume":"163","author":"G Ciriello","year":"2015","unstructured":"Ciriello, G. et al. Comprehensive Molecular Portraits of Invasive Lobular Breast. Cancer. Cell 163, 506\u2013519 (2015).","journal-title":"Cancer. Cell"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-019-55145-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-019-55145-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-019-55145-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,17]],"date-time":"2022-12-17T17:05:45Z","timestamp":1671296745000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-019-55145-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,12,10]]},"references-count":38,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2019,12]]}},"alternative-id":["55145"],"URL":"https:\/\/doi.org\/10.1038\/s41598-019-55145-3","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,12,10]]},"assertion":[{"value":"4 July 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 November 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 December 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"18695"}}